Alemtuzumab-induced lung injury in multiple sclerosis: learning from adversity in three patients

ConclusionsClinicians should be aware to early recognize acute and subacute respiratory adverse events for a promptly management. In these patients re-treatment is challenging.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research